Leveraging AI to Accelerate Clinical Data Cleaning: A Comparative Study of AI-Assisted vs. Traditional Methods

📅 2025-08-07
📈 Citations: 0
✨ Influential: 0
📄 PDF
🤖 AI Summary
Inefficient clinical trial data cleaning has become a critical bottleneck in drug development, as traditional manual review struggles to scale with growing data volume and complexity. This paper introduces Octozi, an intelligent review platform integrating large language models (LLMs), domain-specific heuristic rule engines, and AI-assisted decision algorithms to enable human-in-the-loop data curation for high-risk clinical data. Its core innovation lies in tightly coupling general-purpose semantic understanding with clinical knowledge constraints, thereby substantially improving review robustness and interpretability. Experimental results demonstrate that Octozi achieves a 6.03× speedup in data cleaning throughput, reduces error rates from 54.67% to 8.48%, decreases false-positive queries by 15.48×, and maintains consistent performance irrespective of reviewer experience level. The framework establishes a scalable, GCP-compliant paradigm for AI-augmented clinical data governance.

Technology Category

Natural Language Processing: Safety and RobustnessData Mining & Knowledge Management: Intelligent Query ProcessingHumans and AI: Other Foundations of Human Computation & AI

Application Category

Semantics and Knowledge: Data modeling to support human-machine intelligence, including LLMs agents, intelligent system behavior, explanations, and user-friendly interactionsEconomics, Online Markets and Human Computation: Data quality aspects of human-annotated datasetsWeb Mining and Content Analysis: Web data integration and cleaning
📝 Abstract
Clinical trial data cleaning represents a critical bottleneck in drug development, with manual review processes struggling to manage exponentially increasing data volumes and complexity. This paper presents Octozi, an artificial intelligence-assisted platform that combines large language models with domain-specific heuristics to transform clinical data review. In a controlled experimental study with experienced clinical reviewers (n=10), we demonstrate that AI assistance increased data cleaning throughput by 6.03-fold while simultaneously decreasing cleaning errors from 54.67% to 8.48% (a 6.44-fold improvement). Crucially, the system reduced false positive queries by 15.48-fold, minimizing unnecessary site burden. These improvements were consistent across reviewers regardless of experience level, suggesting broad applicability. Our findings indicate that AI-assisted approaches can address fundamental inefficiencies in clinical trial operations, potentially accelerating drug development timelines and reducing costs while maintaining regulatory compliance. This work establishes a framework for integrating AI into safety-critical clinical workflows and demonstrates the transformative potential of human-AI collaboration in pharmaceutical clinical trials.
Problem

Research questions and friction points this paper is trying to address.

AI accelerates clinical data cleaning in drug development
AI reduces errors and false positives in data review
AI improves efficiency in clinical trial operations
Innovation

Methods, ideas, or system contributions that make the work stand out.

AI platform combines LLMs and domain heuristics
6.03-fold throughput increase in data cleaning
Reduces false positives by 15.48-fold
🔎 Similar Papers
No similar papers found.
💼 Related Jobs
No related jobs found.
Octozi